참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2,5-Dichloronitrobenzene | HCID 6977 | — |
| 반응물 | Potassium Carbonate | HCID 11430 | — |
| 반응물 | Oxalic acid dihydrate | HCID 61373 | — |
| 반응물 | Citadiol, (S)- | HCID 7472057 | — |
| 용매 | Dimethyl Sulfoxide | HCID 679 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | Isopropanol | HCID 3776 | — |
| 생성물 | Escitalopram | HCID 146570 | — |
| 생성물 | Escitalopram Oxalate | HCID 146571 | — |
반응 단계
To a solution of 54.5 kg of (S)-(−)-4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxy-1-butyl]-3-(hydroxymethyl)benzonitrile in 255 lit DMSO was added 66.0 kg of anhydrous K2CO3 and 36.7 kg of 2,5-dichloronitrobenzene at room temperature and stirred for 16 hours at 100-105° C. To the reaction mixture 2550 lit of water was added at about 30° C. The reaction mixture was extracted with toluene, the toluene layer was washed with water and 5% sodium hydroxide solution and after acid base treatment yielded an oily product. The oil was dissolved in 435 lit IPA at 30° C. and 17.7 kg of oxalic acid dihydrate was added to it, heated to 70-75° C., stirred and charcolized the clear solution, cooled, The filtrate was cooled to 5-10° C. slowly and the resultant solid was filtered, dried at 60° C. and micronised to get the oxalic acid salt of (S)-(+)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07989645B2 |
|---|
| 출처 데이터셋 | uspto-grants-2011_08 |
|---|
| ORD ID | ord-62710b81a2d74fc6bc3920cbd6f658f6 |
|---|
| 출처 메모 | uspto-grants-2011_08 |
|---|